Macambira et al. (2009) showed that G-CSF therapy ameliorated myocardial fibrosis and inflammation, and improved electrocardiography (ECG) abnormalities in a mouse model of Chagas disease cardiomyopathy. This evidence concerns the gene CSF3 and Myocardial fibrosis.